Literature DB >> 20548000

Are mastectomy rates really increasing in the United States?

Elizabeth B Habermann1, Andrea Abbott, Helen M Parsons, Beth A Virnig, Waddah B Al-Refaie, Todd M Tuttle.   

Abstract

PURPOSE: After the National Institutes of Health Consensus Statement in 1990, breast-conserving surgery (BCS) became more common while mastectomy rates decreased. However, several recently published single-institution studies have reported an increase in mastectomy rates in the past decade. We conducted a population-based study to evaluate national trends in the surgical treatment of breast cancer from 2000 through 2006. PATIENTS AND METHODS: Using the Surveillance, Epidemiology, and End Results database, we conducted a retrospective cohort analysis of women undergoing surgical treatment for breast cancer. We evaluated variation in mastectomy rates by demographic and tumor factors and calculated differences in mastectomy rates across time. We utilized logistic regression to identify time trends and patient and tumor factors associated with mastectomy, testing for significance using two-sided methods.
RESULTS: We identified 233,754 patients diagnosed with ductal carcinoma in situ or stage I to III unilateral breast cancer from 2000 to 2006. The proportion of women treated with mastectomy decreased from 40.8% in 2000 to 37.0% in 2006 (P < .001). These patterns were maintained across patient and tumor factors. Although the unilateral mastectomy rate decreased during the study period, the contralateral prophylactic mastectomy rate increased. Women were less likely to receive mastectomy over time (odds ratio, 1.18 for 2000 v 2006; 95% CI, 1.14 to 1.23; P < .0001), after adjusting for patient and tumor factors.
CONCLUSION: In contrast to single-institution studies, our population-based analysis found a decrease in unilateral mastectomy rates from 2000 to 2006 in the United States. Variations in referral patterns and patient selection are potential explanations for these differences between single institutions and national trends.

Entities:  

Mesh:

Year:  2010        PMID: 20548000     DOI: 10.1200/JCO.2009.27.6774

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  52 in total

Review 1.  Systematic review of postradiotherapy bronchiolitis obliterans organizing pneumonia in women with breast cancer.

Authors:  Gary R Epler; Eileen M Kelly
Journal:  Oncologist       Date:  2014-10-31

2.  Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial.

Authors:  Pascal Pujol; Christine Lasset; Pascaline Berthet; Catherine Dugast; Suzette Delaloge; Jean-Pierre Fricker; Isabelle Tennevet; Nathalie Chabbert-Buffet; Pascale This; Karen Baudry; Jerome Lemonnier; Lise Roca; Sylvie Mijonnet; Paul Gesta; Jean Chiesa; Helene Dreyfus; Philippe Vennin; Capucine Delnatte; Yves Jean Bignon; Alain Lortholary; Fabienne Prieur; Laurence Gladieff; Anne Lesur; Krishna B Clough; Catherine Nogues; Anne-Laure Martin
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 3.  United States trends in the surgical treatment of primary breast cancer.

Authors:  Todd M Tuttle; Natasha M Rueth; Andrea Abbott; Beth A Virnig
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

4.  Perceptions of care coordination in a population-based sample of diverse breast cancer patients.

Authors:  Sarah T Hawley; Nancy K Janz; Sarah E Lillie; Christopher R Friese; Jennifer J Griggs; John J Graff; Ann S Hamilton; Sarika Jain; Steven J Katz
Journal:  Patient Educ Couns       Date:  2010-11-12

5.  Nipple-Sparing Mastectomy Incisions for Cancer Extirpation Prospective Cohort Trial: Perfusion, Complications, and Patient Outcomes.

Authors:  Elizabeth B Odom; Rajiv P Parikh; Grace Um; Simone W Kantola; Amy E Cyr; Julie A Margenthaler; Marissa M Tenenbaum; Terence M Myckatyn
Journal:  Plast Reconstr Surg       Date:  2018-07       Impact factor: 4.730

6.  Field-in-field IMRT versus 3D-CRT of the breast. Cardiac vessels, ipsilateral lung, and contralateral breast absorbed doses in patients with left-sided lumpectomy: a dosimetric comparison.

Authors:  Duygu Baycan; Didem Karacetin; Ayben Y Balkanay; Yücel Barut
Journal:  Jpn J Radiol       Date:  2012-09-19       Impact factor: 2.374

7.  Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.

Authors:  Justin E Bekelman; Gosia Sylwestrzak; John Barron; Jinan Liu; Andrew J Epstein; Gary Freedman; Jennifer Malin; Ezekiel J Emanuel
Journal:  JAMA       Date:  2014-12-17       Impact factor: 56.272

8.  Cancer Genetic Counseling and Testing in an Era of Rapid Change.

Authors:  Gillian W Hooker; Keelia Rhoads Clemens; John Quillin; Kristen J Vogel Postula; Pia Summerour; Rebecca Nagy; Adam H Buchanan
Journal:  J Genet Couns       Date:  2017-04-22       Impact factor: 2.537

9.  Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States.

Authors:  Reshma Jagsi; Jing Jiang; Adeyiza O Momoh; Amy Alderman; Sharon H Giordano; Thomas A Buchholz; Steven J Kronowitz; Benjamin D Smith
Journal:  J Clin Oncol       Date:  2014-02-18       Impact factor: 44.544

10.  Survival Comparisons for Breast Conserving Surgery and Mastectomy Revisited: Community Experience and the Role of Radiation Therapy.

Authors:  Adedayo A Onitilo; Jessica M Engel; Rachel V Stankowski; Suhail A R Doi
Journal:  Clin Med Res       Date:  2014-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.